Variable | Participants n (%) | |
---|---|---|
Age | ||
18-29 | 5 (3.4) | |
30-49 | 89 (60.5) | |
50-69 | 50 (34.0) | |
70 or above | 3 (2.0) | |
Gender | ||
Female | 95 (64.6) | |
Male | 52 (35.4) | |
Employment field | ||
Clinical oncology | 26 (17.7) | |
Clinical trials | 4 (2.7) | |
Lecturer/educator | 1 (0.7) | |
Medical oncology | 11 (7.5) | |
Nursing | 52 (35.4) | |
Palliative care | 1 (0.7) | |
Pathology | 1 (0.7) | |
Respiratory | 31 (21.1) | |
Research/science | 4 (2.7) | |
Surgery | 10 (6.8) | |
Other | 6 (4.1) | |
Smoking status | ||
Never | 103 (70.1) | |
Ever | 44 (29.9) | |
E-cigarette usea | ||
Never | 132 (90.4) | |
Ever | 14 (9.6) | |
Perceived e-cigarette harma | ||
More harmful than regular cigarettes | 3 (2.1) | |
Equally harmful to regular cigarettes | 14 (9.6) | |
Less harmful than regular cigarettes | 100 (68.5) | |
Don’t know | 29 (19.9) |